| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1790340A2 Combination chemotherapy |
| 05/30/2007 | EP1790329A1 Humectant containing alpha-glycosyl glycyrrhizin as active ingrediant and use thereof |
| 05/30/2007 | EP1789053A2 Method of wound healing using a2b adenosine receptor antagonists |
| 05/30/2007 | EP1789033A2 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/30/2007 | EP1789032A2 Use of thyroid hormone conversion inhibitors |
| 05/30/2007 | EP1789031A2 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists |
| 05/30/2007 | EP1385527B1 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1278517B1 Methods for improving size and appearance of a wound |
| 05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP1107791B1 Hydrogel compositions for the controlled release administration of growth factors |
| 05/30/2007 | CN1972923A Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 05/30/2007 | CN1972708A Compositions for topical treatment |
| 05/30/2007 | CN1972695A Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
| 05/30/2007 | CN1972693A Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology |
| 05/30/2007 | CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 05/30/2007 | CN1970078A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970077A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970029A Medicament for treating onychomycosis |
| 05/30/2007 | CN1970020A A pharmaceutical composition, preparation process and application thereof |
| 05/30/2007 | CN1970015A Enzymatic extraction method of pawpaw polyphenol |
| 05/30/2007 | CN1970014A Chinese medicinal powder or lotion for treating dermatomycosis and method for preparing same |
| 05/30/2007 | CN1970004A Chinese medicinal liniment for treating alopecia |
| 05/30/2007 | CN1969996A Chinese medicinal powder having functions in stopping bleeding, relieving pain, diminishing swelling and promoting granulation and preparation process thereof |
| 05/30/2007 | CN1969994A Powder for treating beriberi |
| 05/30/2007 | CN1969992A Pharmaceutical composition for treating acne and application method thereof |
| 05/30/2007 | CN1969991A Ointment for treating skin ulcer (ulcer-treating capsule) and preparation process thereof |
| 05/30/2007 | CN1969984A Externally applied medicament for treating acne and allergy |
| 05/30/2007 | CN1969975A Formulation for replenishing qi, regenerating blood, tonigying kidney and nourishing face and method for preparing same |
| 05/30/2007 | CN1969960A Pharmaceutical composition for treating acne and application method thereof |
| 05/30/2007 | CN1969943A Western and Chinese medicine integrated ointment for treating ulcer surface of wound on skin |
| 05/30/2007 | CN1969909A Pharmaceutical composition for treating traumatic injury |
| 05/30/2007 | CN1969880A Medicinal powder for treating beriberi |
| 05/30/2007 | CN1969874A Externally applied pharmaceutical composition of abafungin |
| 05/30/2007 | CN1969862A Liniment for treating flat wart |
| 05/30/2007 | CN1969848A Externally applied ointment for treating impetigo |
| 05/30/2007 | CN1969840A Plant extract for treating psoriasis |
| 05/30/2007 | CN1969838A Micro-ecological preparation for treating moniliasis |
| 05/30/2007 | CN1969830A Itraconazole liposome and preparation process thereof |
| 05/30/2007 | CN1969806A Itching-reliving product and production process thereof |
| 05/30/2007 | CN1318439C Preparation method of amygdalin and its application in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 05/30/2007 | CN1318435C Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/30/2007 | CN1318413C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/30/2007 | CN1318388C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/30/2007 | CN1318081C Ant oil liniment and its preparing method |
| 05/30/2007 | CN1318068C Tonic liquid and preparing process thereof |
| 05/30/2007 | CN1318063C Inflammation-resisting itch-stopping lotion and its preparation method |
| 05/30/2007 | CN1318052C Medicine compositions for treating acne, and its preparation method |
| 05/30/2007 | CN1318049C Medicine for treating psoriasis |
| 05/30/2007 | CN1318038C Medicine for treating recurrent psoriasis and its preparing process |
| 05/30/2007 | CN1318037C Medicament for treating foot region damp type dermatosis |
| 05/30/2007 | CN1318030C Methods and compositions useful in enhancing oxygen delivery to cells |
| 05/30/2007 | CN1318029C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1, 2, 3-triazoles |
| 05/30/2007 | CN1318025C Composition for pharmaceutical or dietetic use for combating hair loss |
| 05/30/2007 | CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/30/2007 | CN1318016C New composition including a pigment assembly comprising a mica core |
| 05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
| 05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
| 05/29/2007 | US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 05/29/2007 | US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets |
| 05/29/2007 | US7223779 Azasugar derivative and drug containing the same as the active ingredient |
| 05/29/2007 | US7223775 Stabilized ascorbic acid derivatives |
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1 |
| 05/29/2007 | US7223732 Polypeptides; wound healing agents, antiulcer agents |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/29/2007 | US7223561 Culturing yeast transformed with albumin-encoding nucleotide sequence in a fermentation medium; gene expression, separation, conditioning, adding sodium octanoate; cationic exchange chromatography, elution, ultrafiltration, sterilization, diafiltration, filling vessel |
| 05/29/2007 | US7223450 Chiral compounds |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | US7223393 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents |
| 05/29/2007 | CA2401731C Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 05/29/2007 | CA2401718C Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins |
| 05/24/2007 | WO2007059439A1 Compositions and methods for improving skin health and pelage quality |
| 05/24/2007 | WO2007058360A1 Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient |
| 05/24/2007 | WO2007058359A1 THERAPEUTIC AGENT FOR SKIN OR SKIN REPAIR-PROMOTING AGENT COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 05/24/2007 | WO2007058338A2 Oxazole compound and pharmaceutical composition |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007057598A2 Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof |
| 05/24/2007 | WO2007057583A1 Cosmetic and pharmaceutical compositions comprising lauroyl proline and an ester of anhydrohexitol and of an aliphatic carboxylic acid |
| 05/24/2007 | WO2007057091A1 Flavone sulfates and their use as antioxidants |
| 05/24/2007 | WO2007020479A3 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 05/24/2007 | WO2007019453A3 Treatment of wounds using il-17b |
| 05/24/2007 | US20070117825 Use of amide derivative of ge 2270 factor a3 for the treatment of acne |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117142 Regulation of novel human asparagine-hydroxylases |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116657 Hair growth promotor composition |
| 05/24/2007 | US20070116654 Cosmetics |